Treatment of Cancer Pain by Targeting Cytokines - Test2 - elhamkhani - TriplyDB

Treatment of Cancer Pain by Targeting Cytokines

Treatment of Cancer Pain by Targeting Cytokines

http://www.wikidata.org/entity/Q26779917

about

CXCR1/2 pathways in paclitaxel-induced neuropathic pain An analysis of the types of recently published research in the field of cachexia.Probiotic DSF counteracts chemotherapy induced neuropathic pain.

P2860

Q33618624-6F3B869A-7060-42E4-92EA-8729E9409DC6 Q47568983-31543316-3394-4182-80D8-A451B60FB43A Q55370630-F916C406-1C9D-4ECC-920D-6160215447D5

P2860

Treatment of Cancer Pain by Targeting Cytokines

http://www.wikidata.org/entity/Q26779917

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Treatment of Cancer Pain by Targeting Cytokines

@ast

Treatment of Cancer Pain by Targeting Cytokines

@en

Treatment of Cancer Pain by Targeting Cytokines

@nl

type

label

Treatment of Cancer Pain by Targeting Cytokines

@ast

Treatment of Cancer Pain by Targeting Cytokines

@en

Treatment of Cancer Pain by Targeting Cytokines

@nl

prefLabel

Treatment of Cancer Pain by Targeting Cytokines

@ast

Treatment of Cancer Pain by Targeting Cytokines

@en

Treatment of Cancer Pain by Targeting Cytokines

@nl

P1433

Q26779917-14A1990E-CFB0-4A1B-B948-B6269538E2CB

P1476

Q26779917-9470C737-AE77-4E97-9545-0E28F8ADB23A

P2093

Q26779917-33B54A84-4169-4780-9AB2-3CA015FB4B1F

Q26779917-57A36A65-54A5-4D01-8B50-387233442433

Q26779917-A8B36098-B27D-4475-98E4-7D381FFF8F07

Q26779917-FE1978A5-F8B6-4243-8FF8-60856583D369

P275

Q26779917-B4046976-C156-4F1E-9869-2D27423836FA

P2860

Q26779917-042C0FD0-5529-46FE-8115-AF5B654F10C9

Q26779917-04AA6A42-8601-45DA-9404-6B737EE97867

Q26779917-0A9070A3-CD9E-4827-9C0E-19AF4566E151

Q26779917-1255377B-7AD5-494F-B099-AA48459B8B1B

Q26779917-150A9536-200A-403A-901A-56D6261F63D8

Q26779917-1C92B6D8-0004-4EB5-B63D-038F1D2BBDAD

Q26779917-1D7ECA12-4093-4A4B-8CBB-94E330F36E1E

Q26779917-1E98CBC9-814C-4598-81D7-368954891EC3

Q26779917-27CB3A6E-B8E7-408A-B3A5-0E673AE53B79

Q26779917-2EFA628B-9109-4323-AEBD-673C6A77D3B3

P304

Q26779917-CE35F2FB-E0CC-4D7C-8D2F-9DFDB7BC3C1A

P31

Q26779917-4D7B9067-FF98-429C-931D-DE3291823788

Q26779917-B6E2E732-ED57-4F78-9105-D4043E2B7D8F

P356

Q26779917-2C2A4631-31CD-4B06-9444-55C8213FDBFB

P407

Q26779917-E83BF15D-94E7-46E3-9AA7-54DA224C135F

P478

Q26779917-6A537978-3682-4EF1-AF8C-E462BD485139

P50

Q26779917-D2574AC3-A436-418D-923B-6F668431E238

P5008

Q26779917-967078C0-D852-4B7B-959B-F0B00125ACDF

P577

Q26779917-9313BFC2-A4F0-4133-BBBD-DBDABB5BFFF6

P5875

Q26779917-F4B1A318-F6EB-4FD1-B90F-CEACED45CE27

P698

Q26779917-5EF96A9E-E426-4E90-8B47-6D5DEAE11D51

P921

Q26779917-467326F7-1F8B-44CF-BF81-1409476BFA6D

Q26779917-47D3997B-2286-4D32-926C-7019B746B3C1

Q26779917-497FA601-B9C8-4CC8-A0E6-E05ED3BDD898

P932

Q26779917-79CCC31F-FDEF-4D05-A211-60DC52D94BD0

P356

P1433

Mediators of Inflammation

P1476

Treatment of Cancer Pain by Targeting Cytokines

@en

P2093

D Macedo

http://www.w3.org/2001/XMLSchema#string

I Alho

http://www.w3.org/2001/XMLSchema#string

L Costa

http://www.w3.org/2001/XMLSchema#string

M R Dionísio

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Mechanism of action of lenalidomide in hematological malignancies

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia

Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes

Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors

A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine

Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase II randomized study.

2. Cytokines and chemokines.

The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception.

The potential of statins as part of anti-cancer treatment.

P304

984570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/984570

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283954280

http://www.w3.org/2001/XMLSchema#string

P698

26538839

http://www.w3.org/2001/XMLSchema#string

P921

P932

4619962

http://www.w3.org/2001/XMLSchema#string